Skip Navigation
Menu
Letters |17 September 2019

Polyclonal Staphylococcus aureus Bacteremia

Aleksandra Petrovic Fabijan; Nouri L. Ben Zakour; Josephine Ho; Ruby C.Y. Lin; Jonathan Iredell, PhD; for the Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi Biosciences Corporation *

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 17 September 2019.
* For members of the WBTT and AmpliPhi Biosciences Corporation, see the  Appendix.
  • Westmead Institute for Medical Research and Westmead Hospital of Western Sydney Local Health District, Sydney, Australia (A.P.F., J.H.)
    Westmead Institute for Medical Research and University of Sydney School of Medicine, Sydney, Australia (N.L.B.)
    Westmead Institute for Medical Research, Westmead Hospital of Western Sydney Local Health District, University of Sydney School of Medicine, and University of New South Wales School of Medical Sciences, Sydney, Australia (R.C.L.)
    Westmead Institute for Medical Research, Westmead Hospital of Western Sydney Local Health District, and University of Sydney School of Medicine, Sydney, Australia (J.I.)

    Acknowledgment: The authors thank Joey Lai and Li Ma at Westmead Institute for Medical Research and the staff of the Pathogen Genomics Unit at Westmead Hospital and Ramaciotti Centre (University of New South Wales) for technical advice and sequencing support; Angela Netluch and Patricia Fa for pharmacy support; Stephanie Chan, Katherine Garnham, Sonya Natasha Hutabarat, Cecilia Li, Chris Robson, Andrew Ginn, and the staff of the New South Wales Pathology Microbiology laboratory at Westmead Hospital for help with data and sample collection; and Bethany Bowring for laboratory assistance.

    Financial Support: ABPH provided the investigational product AB-SA01 and partial financial support for work carried out at Western Sydney Local Health District and Westmead Institute for Medical Research to treat patients and analysis of samples, as investigator-led research sponsored and indemnified by Western Sydney Local Health District. Dr. Iredell is supported by grants 1104232 and 1107322 from the Australian National Health and Medical Research Council.

    Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0369.

×
FULL TEXT
Background: Polyclonal, coagulase-negative staphylococci are common contaminants of blood cultures (1), but polyclonal, coagulase-positive staphylococci (Staphylococcus aureus) have yet to be unambiguously identified as a cause of bacteremia.
Objective: To describe a patient with simultaneous and persistent bacteremia from 2 strains of S aureus.
Case Report: A 36-year-old woman who used intravenous drugs was hospitalized in May 2018 for chest pain and fever. She was known to be infected with hepatitis B and C viruses. Blood cultures isolated methicillin-susceptible S aureus (Table and Figure), transthoracic echocardiography identified a vegetation on the septal leaflet...
FULL TEXT
PDF
Not Available
Citations
Citation

Fabijan AP, Ben Zakour NL, Ho J, et al, for the Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi Biosciences Corporation. Polyclonal Staphylococcus aureus Bacteremia. Ann Intern Med. 2019;:. [Epub ahead of print 17 September 2019]. doi: 10.7326/L19-0369

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2019.

DOI: 10.7326/L19-0369

©
2019 American College of Physicians
0 Citations

Related Articles
In adults with S aureus bacteremia, adding rifampin to standard antibiotic therapy did not improve outcomes
Annals of Internal Medicine; 168 (6): JC32
Familial Clustering of Staphylococcus aureus Bacteremia in First-Degree Relatives: A Danish Nationwide Cohort Study
Annals of Internal Medicine; 165 (6): 390-398
Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia: A Meta-Analysis
Annals of Internal Medicine; 119 (4): 304-311
Therapy of Staphylococcus aureus Bacteremia Associated with a Removable Focus of Infection
Annals of Internal Medicine; 84 (5): 558-560
View MoreView Less

Journal Club
In adults with S aureus bacteremia, adding rifampin to standard antibiotic therapy did not improve outcomes
Annals of Internal Medicine; 168 (6): JC32
Review: Pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality
Annals of Internal Medicine; 150 (10): JC5-4
View MoreView Less

Related Topics
Multi-Organ Failure and Sepsis
Pulmonary/Critical Care

Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.

PubMed Articles
Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.
PLoS One 2019;14(9):e0223079.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×